Showing 321–336 of 414 resultsSorted by popularity
Ripex-225 is a complementary triple-blend injectable combining Testosterone Propionate, Trenbolone Acetate, and Drostanolone Propionate at 225mg/ml. It simultaneously activates androgen receptors, inhibits aromatase, and maintains physiological androgen levels for extensive anabolic signaling.
Estradiol Cypionate is an injectable estrogen receptor agonist that provides sustained 17-beta-estradiol release through gradual cypionate ester cleavage. It activates nuclear ER-alpha and ER-beta receptors for investigating estrogen-mediated gene transcription.
Vitamin B12 (Methylcobalamin) Injection 1mg/ml is an essential methyl-donor cofactor that catalyzes homocysteine-to-methionine conversion and supports myelin sheath integrity. The injectable delivery bypasses gastrointestinal absorption for superior bioavailability.
A dnp research tool. The biochemical activity of DNP is defined by its ability to act as a proton ionophore within the mitochondria.
Prednisone is a glucocorticoid prodrug that undergoes hepatic conversion to active prednisolone, which binds cytosolic glucocorticoid receptors to translocate into the nucleus and repress NF-kB-driven pro-inflammatory gene transcription.
M1T (17a-Methyl-1-testosterone) is a highly potent C17-alpha-alkylated DHT derivative that delivers exceptional anabolic signaling through direct androgen receptor activation. A primary research compound for studying extreme nitrogen retention and rapid muscle hypertrophy.
Salbutamol is a selective Beta-2 adrenergic receptor agonist that activates adenylate cyclase to increase cAMP levels, driving both bronchodilation and lipolysis. A research tool for investigating adrenergic signaling in respiratory and metabolic models.
Halotestin (Fluoxymesterone) is an extremely potent C17-alkylated androgen featuring 9-alpha-fluoro and 11-beta-hydroxy modifications that maximize androgen receptor binding while preventing aromatization. A trusted compound for investigating central nervous system androgenic signaling.
Letrozole (Femara) is a non-steroidal Type II aromatase inhibitor that competitively coordinates with the CYP19A1 heme iron, reversibly blocking androgen-to-estrogen conversion. A high-potency research tool for achieving strong estrogen suppression.
Flibanserin is a multifunctional serotonin ligand that acts as a 5-HT1A agonist and 5-HT2A antagonist, shifting the neurochemical balance to increase dopamine and norepinephrine while reducing serotonin inhibition. A targeted tool for female libido and neurotransmitter research.
Myostatin inhibitor SARM for muscle growth research. Study follistatin upregulation and AR activation.
Andarine (S4) is a tissue-selective SARM that binds the androgen receptor with high affinity and preferentially activates androgen response elements in skeletal muscle and bone over prostate tissue. Its 4-hour half-life requires optimized dosing protocols.
AICAR is a cell-permeable nucleoside analog that converts intracellularly to ZMP, potently activating AMPK to mimic exercise-induced metabolic stress. An oral formulation for investigating mitochondrial biogenesis and insulin-independent glucose disposal.
SR9009 is a Rev-ErbA nuclear receptor agonist that suppresses BMAL1 and CLOCK gene transcription to reprogram circadian metabolic rhythms. It upregulates mitochondrial biogenesis and fatty acid oxidation in skeletal muscle, functioning as an exercise mimetic.
MAST Blend-200 is a dual-ester Drostanolone formulation combining Propionate (rapid) and Enanthate (sustained) esters for staggered androgen receptor activation. The 2-methyl modification prevents aromatization, delivering pure DHT-derivative signaling.
End of content
End of content
No products in the cart.
